GB1572119A - Pharmaceutical spasmolytic composition - Google Patents

Pharmaceutical spasmolytic composition Download PDF

Info

Publication number
GB1572119A
GB1572119A GB2043377A GB2043377A GB1572119A GB 1572119 A GB1572119 A GB 1572119A GB 2043377 A GB2043377 A GB 2043377A GB 2043377 A GB2043377 A GB 2043377A GB 1572119 A GB1572119 A GB 1572119A
Authority
GB
United Kingdom
Prior art keywords
composition
spasmolytic
allyl
values
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2043377A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chimicasa GmbH
Original Assignee
Chimicasa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chimicasa GmbH filed Critical Chimicasa GmbH
Publication of GB1572119A publication Critical patent/GB1572119A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C07C69/01—Vinyl esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/16—Acetic acid esters of dihydroxylic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB2043377A 1976-05-18 1977-05-16 Pharmaceutical spasmolytic composition Expired GB1572119A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74973A LU74973A1 (it) 1976-05-18 1976-05-18

Publications (1)

Publication Number Publication Date
GB1572119A true GB1572119A (en) 1980-07-23

Family

ID=19728242

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2043377A Expired GB1572119A (en) 1976-05-18 1977-05-16 Pharmaceutical spasmolytic composition

Country Status (9)

Country Link
JP (1) JPS52142030A (it)
BE (1) BE854716A (it)
CA (1) CA1075604A (it)
DE (1) DE2719623A1 (it)
ES (1) ES458893A1 (it)
FR (1) FR2362625A1 (it)
GB (1) GB1572119A (it)
LU (1) LU74973A1 (it)
NL (1) NL7705436A (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466458A1 (fr) * 1979-09-27 1981-04-10 Mathieu Andre Nouveaux medicaments derives de l'eugenol
US4533746A (en) * 1983-06-16 1985-08-06 International Flavors & Fragrances Inc. 2-Methoxy-4-(2-methylpropenyl) phenyl ester of isobutyric acid, flavor use thereof and process for preparing same

Also Published As

Publication number Publication date
FR2362625A1 (fr) 1978-03-24
LU74973A1 (it) 1977-12-22
BE854716A (fr) 1977-09-16
FR2362625B1 (it) 1980-01-18
JPS52142030A (en) 1977-11-26
DE2719623A1 (de) 1977-12-08
ES458893A1 (es) 1978-03-16
CA1075604A (en) 1980-04-15
NL7705436A (nl) 1977-11-22

Similar Documents

Publication Publication Date Title
CA2044676C (en) Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
US4139638A (en) Methods for the treatment of hirsutism
JP4231906B2 (ja) 末梢カンナビノイド受容体に特異的なアゴニスト
CA1239587A (en) Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPH0154339B2 (it)
US3995060A (en) Antiandrogenic agents and method for the treatment of androgen dependent disease states
US4172151A (en) Anti-inflammatory method
WO2019136219A1 (en) Treating autoimmune disorders with acetylcholinesterase inhibitors
GB1569242A (en) Bis-(triiodobenzoylamino)-oxaalkanes for use in x-ray contrast media and process for their preparation
US5491171A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
GB1572119A (en) Pharmaceutical spasmolytic composition
JPH0239510B2 (it)
JPS58213716A (ja) 制癌剤
US3251739A (en) Method of treating angina pectoris
US4119730A (en) Treating muscle spasms
Brucculeri et al. Reversal of Citalopram‐Induced Junctional Bradycardia with Intravenous Sodium Bicarbonate
JPS6024764B2 (ja) インドメタシンを含む局所薬
US2572828A (en) Alkoxyalkyl esters of monoiodomono-alkoxybenzoic acids
US3183151A (en) Treatment of hypocholeresis with 1-cyclohexyl-2-methyl-1-propanol
US6436916B1 (en) Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
US2609323A (en) Alkyl vanillate ointment
US3461152A (en) Mephenesin acetylsalicylate
US3172812A (en) Gamma-aminototyryl nicotinate for neurogenic vasospasm
US3639638A (en) Coronary vessel dilation
US4232043A (en) Anti-inflammatory method

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee